Brief: Cerus Announces Presentation Of Study Results With Intercept-Treated COVID-19 Convalescent Plasma At The American Society Of Hematology Annual Meeting
Dec 4 (Reuters) - Cerus Corp CERS.O :
* CERUS CORPORATION ANNOUNCES PRESENTATION OF STUDY RESULTS
WITH
INTERCEPT-TREATED COVID-19 CONVALESCENT PLASMA AT THE AMERICAN
SOCIETY OF HEMATOLOGY ANNUAL MEETING
* CERUS-DATA DEMONSTRATE ABILITY TO IDENTIFY EFFECTIVE CCP
DURING
EPIDEMICS THAT CAN BE RAPIDLY INTRODUCED INTO ROUTINE PRACTICE
Source text for Eikon: ID:nBw9NhYDka
Further company coverage: CERS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cerus
See all newsCerus Corp reports results for the quarter ended June 30 - Earnings Summary
Cerus Q2 adjusted EBITDA misses estimates, raises 2026 outlook
Brief: Cerus Q2 Gross Profit USD 29.5 Million
Cerus Corp expected to post a loss of 1 cent a share - Earnings Preview
Brief: Cerus Corporation Closes New Debt Facility Of Up To $110 Million